WO2002012256A1 - Method for purification of acarbose - Google Patents
Method for purification of acarbose Download PDFInfo
- Publication number
- WO2002012256A1 WO2002012256A1 PCT/US2001/024729 US0124729W WO0212256A1 WO 2002012256 A1 WO2002012256 A1 WO 2002012256A1 US 0124729 W US0124729 W US 0124729W WO 0212256 A1 WO0212256 A1 WO 0212256A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- acid
- acarbose
- exchanger
- cation
- anion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 0 CC1C(*)C(C)C(N)OC1C Chemical compound CC1C(*)C(C)C(N)OC1C 0.000 description 3
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
- C07H1/06—Separation; Purification
- C07H1/08—Separation; Purification from natural products
Definitions
- the present invention relates to a novel process for the purification of acarbose.
- Acarbose also known as 0-4, 6-Dideoxy-4 [ [ [IS- (l ⁇ , 4 , 5 ⁇ , 6 ) ] -4 , 5, 6-trihydroxy-3- (hydroxmethyl) -2- cyclohexen-1-yl] amino] - -D-glycopyranosyl- (1 ⁇ 4) -O- -D- glucopyranosyl- (1 ⁇ 4) -D-glucose, or 4", 6"-dideoxyl-4"- [ (IS) - (1, 4, 6/5) -4, 5, 6-trihydrox-3-hydroxymethyl-2- cyclohexenylamino]maltotriose, having the following formula (I) .
- Acarbose is a potent -glucosidase inhibitor that reduces sugar absorption in the gastrointestinal tract. It is used as an orally administered anti-diabetic drug sold under the trademark GLUCOBAY ® and is available for the treatment of diabetes mellitus in humans.
- U.S. Pat. No. 4,062,950 and Ger. Pat. No. 2,347,782 describe the isolation of acarbose from strains of Actinoplanes . These processes employ the use of ion-exchangers to adsorb acarbose from fermentation broths; but the ion-exchange steps contain nitrate anion. The presence of nitrate anion causes impurities to adsorb onto the ion-exchange resins and thus contaminates the acarbose. The presence of impurities also complicates the purification process because additional purification steps are needed to remove these impurities.
- the present invention provides a process for the purification of. acarbose using ion-exchange chromatography; more specifically, cation-exchange chromatography.
- the present invention provides the use of a strong cation-exchange to adsorb acarbose in the presence of an anion of weak acid.
- the present invention provides a method of purifying acarbose, which comprises the steps of:
- the present invention provides a method of purifying acarbose, comprising the steps of:
- X anion refers to a negatively-charged ion and the term “cation” refers to a positively-charged ion.
- ion exchange chromatography refers to a charged ion-exchanger where it involves the binding and elution of a target molecule (e.g., acarbose) .
- a "cation-exchanger” is a type of charged ion-exchanger that possesses a net negative charge on its resin which acarbose would binds to.
- a strong ion- exchanger is one which remains almost fully ionized over a wide pH range whereas a weak exchanger is ionized over a small pH range.
- strong cation-exchanger and “strong acid cation-exchanger” are used interchangeably and they refer to the same types of cation-exchangers.
- strong acid cationic exchange resins which may be used are those having sulfonic acid (S03 ⁇ H + ) groups. These include the commercial products Amberlite® IR-118, IR-120, 252H; Amberlyst® 15, 36; Amberject® 1200 (H) (Rohm and Haas) ; Dowex® 50 wX series, Dowex® HCR-W2, Dowex® 650C, Dowex® Marathon C, Dowex® DR-2030, and Dowex® HCR-S, ion exchange resin (Dow Chemical Co.); Diaion® SK 102 to 116 resin series (Mitsubishi Chemical Corp.) And Lewatit SP 120 (Bayer).
- the preferred strong acid cationic exchange resins are Amberlite® 120, Dowex® 50 WX and Diaion® SK series.
- Preferred cation-exchangers also include Amberlite ® .
- Amerblite ion-exchanger employs a polystyrene resins as the matrix.
- Amberlite® 252 resin in H + form is an example for cation-exchanger in H+ form.
- Preferred cation-exchanger is Amberlite® 252 in H + form.
- Cation ion-exchangers further include sulpho, sulphomethyl (i.e., methyl sulfonate), and sulphopropyl forms.
- Preferable cation-ion exchangers include the functional group of meththyl sulfonate.
- Exemplary strong cation-exchangers include Mini S ® (methyl sulfonate) , Mono S ® (methyl sulfonate) , SP Sepharose ® (methyl sulfonate), SOURCE 15S ® , 30S ® (methyl sulfonate) and the like.
- Weak cation ion-exchange resins include those which have carboxylic acid groups as well as carboxy and carboxymethyl forms.
- Preferable weak cation- exchangers include the functional group of -COOH.
- An exemplary weak cation-exchangers is CM Sepharose Fast Flow ® .
- anion-exchanger refers to anion-exchange resins that possess a net positive charge.
- a preferred anion-exchange resin include resins that contain a guarternary amine functional group. Diethylaminoethyl (DEAE) exchangers and carboxymethyl (CM) exchangers are usually used as anion exchangers .
- DEAE Diethylaminoethyl
- CM carboxymethyl
- an anion of a ak acid refers to an anion of organic acids or phosphate.
- the anion of weak acid is selected from the group consisting of tartarate, succinate, citrate, acetate, formate, malonate, oxalate, phthalate, benzoate and phosphate .
- weak acid specifically refers to an acid selected from the group consisting of tartaric acid, succinic acid, citric acid, acetic acid, formic acid, malonic acid, oxalic acid, phthalic acid, benzoic acid and phosphoric acid.
- Particulates refers to cellular debris and particles that are present in a fermentation broth. Particulates also include mycelium.
- M refers to a concentration in molar.
- the yield % is based on w/w. Each peak has an area on a HPLC chromatogram. "Area %" refers to the peak area of purified product divided by the total area of all peaks multiplied by 100.
- yield of anion exchange refers to yield % of acarbose prior to cation-exchange column.
- anions were changed to an an anion of a weak acid (herein also known as “investigated anion”). This was achieved by a particular anion-exchanger.
- summarized yield refers to anion-exchange yield multiplied by cation-exchange yield. Because anion exchangers generally have some non-specific absorption ability, it causes a loss.
- the present invention provides a process of purifying acarbose employing the use of a cation-exchanger. More specifically, the purification of acarbose using cation-exchanger in the presence of an anion of a weak acid.
- the present invention provides a process of purifying acarbose employing the presence of an anion of a weak acid during the cation- exchanger.
- anion of a weak acid it is found that the impurities present in the fermentation broth cannot adsorb onto the strong acid cation-exchanger. Consequently, only acarbose adsorbs onto the strong acid cation-exchanger, and results in a better purification. This results in selective adsorption of acarbose. Accordingly, we found a novel phenomenon that adsorption of acarbose without the impurities .
- the present invention provides the acarbose adsorbing onto a strong acid cation-exchanger without previous desalting.
- counter-ions such as chloride, nitrate and the like
- the present invention provides an unexpected phenomenon where it is found that the specific type of anion can influence the selectivity and adsorption capacity of the cation- exchanger.
- the present invention provides a purification process for acarbose employing an appropriate anion which is selected from the group consisting of tartarate, succinate, citrate, acetate, formate, malonate, oxalate, phthalate, benzoate, and phosphate .
- the present invention provides a process for purifying acarbose employing the use of multiple ion-exchangers. Fermentation broth is allowed to adsorb onto multiple ion-exchangers successively. In particular, acarbose is eluted from an anion-exchanger prior to the adsorption onto a cation-exchanger. The use of successive exchangers has proved to be effective in purifying acarbose.
- a preferred embodiment for the anion-exchanger is an anion exchanger resin in OH " form.
- a preferred embodiment for the anions used in the anion-exchange include tartarate, succinate, citrate, acetate, formate, malonate, oxalate, phthalate, benzoate, and phosphate.
- a preferred embodiment for the cation-exchanger is a strong cation-exchanger.
- the presently most preferred embodiment includes a cation-exchanger that is a strong cation exchange resin in acid form.
- the present invention employs a cation-exchanger whereby a strong cation-exchanger resin is in calcium form.
- the particulates present in the fermentation broth are removed.
- the techniques to remove the particulates includes the sedimentation as well as filtering as one of skill in the art would appreciate.
- Fermentation broth containing acarbose can be filtered prior to the application onto the cation-exchangers.
- the filtration of fermentation broth removes any particulates and cell debris.
- the filter is a pre-coat vacuum drum filter.
- filters of a similar kind can serve a similar function as to pre-clear the fermentation broth prior to the chromatography purification.
- the filtration of fermentation broth is repeated at least twice.
- the fermentation broth containing acarbose is adjusted to an acidic pH prior to filtration.
- the pH of the fermentation broth is adjusted to a pH of about 4.0 to a pH of about 6.0 with a mineral acid or a weak acid.
- a mineral acid is defined herein as a strong acidic solution such as hydrochloric acid, sulphuric acid, nitric acid, phosphoric acid and the like.
- a weak acid is selected from the group consisting of tartaric acid, succinic acid, citric acid, acetic acid, formic acid, malonic acid, oxalic acid, phthalic acid, benzoic acid, and phosphoric acid.
- a preferred embodiment for a weak acid is acetic acid.
- the present invention relates to a process of purifying acarbose using two ion-exchangers.
- the first ion- exchanger is an anion-exchanger.
- the first anion-exchanger is in the acetate, tartarate or succinate forms.
- the second ion-exchanger is a strong cation-exchanger.
- the second cation- exchanger is a strong cation-exchanger in acid form.
- the present invention relates to a process of purifying acarbose, wherein acarbose adsorbed onto a cation-exchanger is eluted with either hydrochloric acid or weak acids.
- the present invention relates to a process of purifying acarbose, wherein a solvent is used for the precipitation of acarbose from the eluant.
- a solvent is used for the precipitation of acarbose from the eluant.
- the solvent includes alcohol, a mixture of alcohols and acetone, acetonitrile, ester of acetic acid, ester of formic acid, ester of propionic acid or the like.
- EXAMPLE 1 A fermentation broth of 122 kg was acidified with sulfuric acid to about pH 4.0-4.5. The acidified fermentation broth was filtered on pre-coat vacuum drum filter. The filtered mycelium was washed with water. The fermentation broth contained 537 gram active substance. The filtration yield was 91% (w/w) . The volume of the filtrate was 227 liters. The pH of the acidified filtrate was adjusted to about 2.0-2.2 with sulfuric acid and it was filtered again pre-coat drum filter. The volume of the filtrate was 223 liters. The filtration yield was 94% (w/w) .
- the pH of the filtrate of about 2.0-2.2 was adjusted to about 4.0-7.0 with anion-exchange resin in basic form.
- the yield of the pH adjust was 94.5% (w/w) .
- the adjusted filtrate was poured through on ion- exchange column.
- the ion-exchange column contained 20 liters anion-exchange resin in acetate form.
- the flow rate was 12.5 liters/hour.
- the effluent flow was conducted without desalinating continuously to another ion-exchange column containing 22 liters strong acid cation-exchanger in acid form.
- the ion-exchange was finished with 50 liters rinsing water.
- the active substance that were bound or adsorbed onto the ion-exchange resin was eluted with 0.02 M hydrochloric acid.
- the eluants were collected into different fractions using a fraction collector.
- a main fraction of the eluants contained 374 gram active substance.
- the volume of the main fraction was 37.5 liters.
- the main fraction was analyzed by HPLC.
- the pH of the main fraction was adjusted to about 4.0-5.0 with anion- exchange resin in basic form.
- the first ion-exchange column contained 60 ml anion-exchange resin in tartarte form.
- the second column contained 60 ml strong acid cation-exchanger in acid form.
- the applied flow rate was 40 ml/hour.
- the ion-exchange was finished with 120 L rinsing water.
- the adsorbed active substance was eluted from the second column with 0.02 M hydrochloric acid.
- the main fraction contained 4.4 gram acarbose.
- the main fraction was analyzed by HPLC. There were less than 2% related substances on the HPLC chromatogram.
- the main fraction was concentrated after removing chloride ions with anion exchange resin in basic form. The concentration of acarbose was about 50% (w/w) .
- the first ion-exchange column contained 60 mL anion-exchange resin in succinate form.
- the second column contained 60 mL strong acid cation-exchanger in acid form.
- the applied flow rate was 40 mL/hour.
- the ion-exchange was finished with 120 mL rinsing water.
- the adsorbed active substance was eluted from the second column with 0.02 M hydrochloric acid.
- the main fraction contained 4.3 acarbose.
- the main fraction was analyzed with HPLC analysis method. There were less than 2% related substances on the HPLC chromatogram.
- the main fraction was concentrated after removing chloride ions with anion exchange resin in basic form. The concentration of acarbose was about 50% by w/w.
- the acarbose was precipitated in the presence of ethanol.
- the crystals were filtered and dried.
- the 3.9 gram product contained less than 1% related substance.
- EXAMPLE 4 The purification of acarbose illustrated in the above-mentioned Example 1 were using strong ion- exchanger in the presence of an anion of weak acids such as acetate, tartarte or succinate.
- a fermentation broth of 60 kg was acidified with acetic acid to Ph about 4.0-6.0. Acid was added to fermentation broth and mixed. The acidified fermentation broth was filtered on pre-coat vacuum drum filter. The filtered mycelium was washed with water. The fermentation broth contained 160 gram active substance. The filtration yield was 91% (w/w) using a HPLC method. The volume of the filtrate was 88 litres.
- the filtrate was poured through on ion-exchange column.
- the ion-exchange column contained 8 litres strong acid cation-exchanger in acid form (Amberlite ® 252 in H + form) .
- the ion-exchange was finished with 8 litres rinsing water.
- the active substance that were bound or adsorbed onto the ion-exchange resin was eluted with 0.02 M hydrochloric acid.
- the flow-rate was 1 litre/hour.
- Preferred solution is hydrochloric acid.
- Preferred concentration is 0.0002 M - 0.03 M. Most preferred concentration is 0.005 M - 0.02 M.
- the eluants were collected into different fractions using a fraction collector. A main fraction of the eluants contained 124 gram active substance.
- the yield of ion-exchange purification process was 85% w/w as determined by HPLC.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2001284741A AU2001284741A1 (en) | 2000-08-07 | 2001-08-07 | Method for purification of acarbose |
| EP01963821A EP1309601A1 (en) | 2000-08-07 | 2001-08-07 | Method for purification of acarbose |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22349200P | 2000-08-07 | 2000-08-07 | |
| US60/223,492 | 2000-08-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2002012256A1 true WO2002012256A1 (en) | 2002-02-14 |
Family
ID=22836739
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2001/024729 Ceased WO2002012256A1 (en) | 2000-08-07 | 2001-08-07 | Method for purification of acarbose |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP1309601A1 (en) |
| AU (1) | AU2001284741A1 (en) |
| WO (1) | WO2002012256A1 (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6734300B2 (en) | 2001-10-26 | 2004-05-11 | Va, Farmaceutska Industrija, Dd | Acarbose purification process |
| CN102030786A (en) * | 2010-11-12 | 2011-04-27 | 丽珠集团新北江制药股份有限公司 | Preparation method of acarbose |
| CN104693250A (en) * | 2015-03-06 | 2015-06-10 | 成都大学 | Method for purifying acarbose from acarbose-containing solution |
| CN106397506A (en) * | 2016-08-31 | 2017-02-15 | 杭州中美华东制药有限公司 | Method for purifying high-quality acarbose |
| CN108148104A (en) * | 2017-12-25 | 2018-06-12 | 苏州纳微科技有限公司 | A kind of isolation and purification method of acarbose |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2719912A1 (en) * | 1977-05-04 | 1978-11-16 | Bayer Ag | METHOD OF INSULATION FROM 0 CURVED CLAMP ON -4,6-DIDEOXY-4 ANGULAR CLAMP ON ANGULAR CLAMP ON 1 S- (1,4,6 / 5) -4,5,6-TRIHYDROXY-3-HYDROXYMETHYL-2-CYCLOHEXEN -1-YL SQUARE CLIP CLOSE -AMINO SQUARE CLIP CLOSE -ALPHA-D-GLUCOPYRANOSYL CURVED CLIP CLOSE - (1- RIGHT ARROW 4) -0- ALPHA-D-GLUCOPYRANOSYL- (1- RIGHT ARROW 4) -D- GLUCOPYRANOSE FROM BRUSH |
| US4767850A (en) * | 1984-10-25 | 1988-08-30 | Bayer Aktiengesellschaft | Process for the purification of acarbose with polymers |
| US4904769A (en) * | 1985-12-13 | 1990-02-27 | Bayer Aktiengesellschaft | Highly pure acarbose |
-
2001
- 2001-08-07 AU AU2001284741A patent/AU2001284741A1/en not_active Abandoned
- 2001-08-07 WO PCT/US2001/024729 patent/WO2002012256A1/en not_active Ceased
- 2001-08-07 EP EP01963821A patent/EP1309601A1/en not_active Withdrawn
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2719912A1 (en) * | 1977-05-04 | 1978-11-16 | Bayer Ag | METHOD OF INSULATION FROM 0 CURVED CLAMP ON -4,6-DIDEOXY-4 ANGULAR CLAMP ON ANGULAR CLAMP ON 1 S- (1,4,6 / 5) -4,5,6-TRIHYDROXY-3-HYDROXYMETHYL-2-CYCLOHEXEN -1-YL SQUARE CLIP CLOSE -AMINO SQUARE CLIP CLOSE -ALPHA-D-GLUCOPYRANOSYL CURVED CLIP CLOSE - (1- RIGHT ARROW 4) -0- ALPHA-D-GLUCOPYRANOSYL- (1- RIGHT ARROW 4) -D- GLUCOPYRANOSE FROM BRUSH |
| US4767850A (en) * | 1984-10-25 | 1988-08-30 | Bayer Aktiengesellschaft | Process for the purification of acarbose with polymers |
| US4904769A (en) * | 1985-12-13 | 1990-02-27 | Bayer Aktiengesellschaft | Highly pure acarbose |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6734300B2 (en) | 2001-10-26 | 2004-05-11 | Va, Farmaceutska Industrija, Dd | Acarbose purification process |
| CN102030786A (en) * | 2010-11-12 | 2011-04-27 | 丽珠集团新北江制药股份有限公司 | Preparation method of acarbose |
| CN104693250A (en) * | 2015-03-06 | 2015-06-10 | 成都大学 | Method for purifying acarbose from acarbose-containing solution |
| CN106397506A (en) * | 2016-08-31 | 2017-02-15 | 杭州中美华东制药有限公司 | Method for purifying high-quality acarbose |
| CN108148104A (en) * | 2017-12-25 | 2018-06-12 | 苏州纳微科技有限公司 | A kind of isolation and purification method of acarbose |
Also Published As
| Publication number | Publication date |
|---|---|
| EP1309601A1 (en) | 2003-05-14 |
| AU2001284741A1 (en) | 2002-02-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR900008743B1 (en) | Process for purifying anthracyclimonic glycosides by selective adsorption on resins | |
| JP4173124B2 (en) | Purification method of vancomycin hydrochloride | |
| EP1309601A1 (en) | Method for purification of acarbose | |
| US20020111320A1 (en) | Method for purification of acarbose | |
| US20020183262A1 (en) | Method for purification of acarbose | |
| KR100470524B1 (en) | Manufacturing method of moenomycin A | |
| CN1521176A (en) | Method for producing highly pure acarbose | |
| JP3992497B2 (en) | High purity acarbose manufacturing method | |
| US6734300B2 (en) | Acarbose purification process | |
| CN115260294B (en) | A method for separating and purifying teicoplanin | |
| EP1003761A2 (en) | A process for the purification of acarbose | |
| Chaiet et al. | Phosphonomycin: Isolation from fermentation sources | |
| EP0679655B1 (en) | Process for producing ascorbic acid derivatives | |
| US5374771A (en) | Process for the preparation of high-purity deferoxamine salts | |
| CN106220715B (en) | A kind of preparation method of bleomycin | |
| RU2333963C1 (en) | Chromatographic method of eremomycin purification | |
| CN112940083A (en) | High-purity polymyxin sulfate B1 crystal form and preparation method thereof | |
| SU1731772A1 (en) | Method for isolation of tetracycline-base from the aqueous solution | |
| KR920000102B1 (en) | Method for Purifying Anthracyclinone Glycoside | |
| JPS5817594B2 (en) | Cephalosporin C | |
| WO1998026085A1 (en) | Processes for producing vancomycin | |
| JPH02178288A (en) | Purification of 3-hydroxymethyl-7-aminocephem carboxylic acid | |
| JPH07188249A (en) | Purification method of cephalosporin compounds | |
| JPH0283394A (en) | Purification method of S-adenosyl-L-homocysteine | |
| KR20020067044A (en) | A multistage process for the preparation of highly pure deferoxamine mesylate salt |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| WWE | Wipo information: entry into national phase |
Ref document number: 2001963821 Country of ref document: EP |
|
| WWP | Wipo information: published in national office |
Ref document number: 2001963821 Country of ref document: EP |
|
| REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
| WWW | Wipo information: withdrawn in national office |
Ref document number: 2001963821 Country of ref document: EP |
|
| NENP | Non-entry into the national phase |
Ref country code: JP |